MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Dimension Therapeutics Company Profile (NASDAQ:DMTX)

Consensus Ratings for Dimension Therapeutics (NASDAQ:DMTX) (?)
Ratings Breakdown: 2 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.71)
Consensus Price Target: $16.50 (105.99% upside)

Analysts' Ratings History for Dimension Therapeutics (NASDAQ:DMTX)
Show:
DateFirmActionRatingPrice TargetActions
5/14/2016Canaccord GenuityReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/30/2016Goldman SachsDowngradeBuy -> Neutral$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/29/2016Chardan CapitalReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/29/2016Citigroup Inc.Lower Price TargetBuy$18.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/17/2016Cantor FitzgeraldInitiated CoverageBuy$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/3/2015Wells FargoInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/6/2015Roth CapitalInitiated CoverageBuy$31.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/30/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha